These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 29436039)

  • 21. Progression of cortical thinning in early Parkinson's disease.
    Ibarretxe-Bilbao N; Junque C; Segura B; Baggio HC; Marti MJ; Valldeoriola F; Bargallo N; Tolosa E
    Mov Disord; 2012 Dec; 27(14):1746-53. PubMed ID: 23124622
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mild cognitive impairment is linked with faster rate of cortical thinning in patients with Parkinson's disease longitudinally.
    Hanganu A; Bedetti C; Degroot C; Mejia-Constain B; Lafontaine AL; Soland V; Chouinard S; Bruneau MA; Mellah S; Belleville S; Monchi O
    Brain; 2014 Apr; 137(Pt 4):1120-9. PubMed ID: 24613932
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Altered functional connectivity in the default mode network is associated with cognitive impairment and brain anatomical changes in Parkinson's disease.
    Lucas-Jiménez O; Ojeda N; Peña J; Díez-Cirarda M; Cabrera-Zubizarreta A; Gómez-Esteban JC; Gómez-Beldarrain MÁ; Ibarretxe-Bilbao N
    Parkinsonism Relat Disord; 2016 Dec; 33():58-64. PubMed ID: 27659747
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Longitudinal intracortical diffusivity changes in de-novo Parkinson's disease: A promising imaging biomarker.
    Sampedro F; Martínez-Horta S; Marín-Lahoz J; Pagonabarraga J; Kulisevsky J
    Parkinsonism Relat Disord; 2019 Nov; 68():22-25. PubMed ID: 31621613
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Brain degeneration in Parkinson's disease patients with cognitive decline: a coordinate-based meta-analysis.
    Mihaescu AS; Masellis M; Graff-Guerrero A; Kim J; Criaud M; Cho SS; Ghadery C; Valli M; Strafella AP
    Brain Imaging Behav; 2019 Aug; 13(4):1021-1034. PubMed ID: 29971686
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cortical activity in Parkinson's disease during executive processing depends on striatal involvement.
    Monchi O; Petrides M; Mejia-Constain B; Strafella AP
    Brain; 2007 Jan; 130(Pt 1):233-44. PubMed ID: 17121746
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Apathy in Mild Parkinson's Disease: Neuropsychological and Neuroimaging Evidence.
    Alzahrani H; Antonini A; Venneri A
    J Parkinsons Dis; 2016 Oct; 6(4):821-832. PubMed ID: 27567885
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cortical Thickness, Surface Area and Subcortical Volume Differentially Contribute to Cognitive Heterogeneity in Parkinson's Disease.
    Gerrits NJ; van Loenhoud AC; van den Berg SF; Berendse HW; Foncke EM; Klein M; Stoffers D; van der Werf YD; van den Heuvel OA
    PLoS One; 2016; 11(2):e0148852. PubMed ID: 26919667
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cortical gray and subcortical white matter associations in Parkinson's disease.
    Sterling NW; Du G; Lewis MM; Swavely S; Kong L; Styner M; Huang X
    Neurobiol Aging; 2017 Jan; 49():100-108. PubMed ID: 27776262
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cognitive and cortical thinning patterns of subjective cognitive decline in patients with and without Parkinson's disease.
    Hong JY; Yun HJ; Sunwoo MK; Ham JH; Lee JM; Sohn YH; Lee PH
    Parkinsonism Relat Disord; 2014 Sep; 20(9):999-1003. PubMed ID: 25001316
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Progression of Parkinson's disease patients' subtypes based on cortical thinning: 4-year follow-up.
    Uribe C; Segura B; Baggio HC; Abos A; Garcia-Diaz AI; Campabadal A; Marti MJ; Valldeoriola F; Compta Y; Bargallo N; Junque C
    Parkinsonism Relat Disord; 2019 Jul; 64():286-292. PubMed ID: 31103485
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mild cognitive impairment in patients with Parkinson's disease is associated with increased cortical degeneration.
    Hanganu A; Bedetti C; Jubault T; Gagnon JF; Mejia-Constain B; Degroot C; Lafontaine AL; Chouinard S; Monchi O
    Mov Disord; 2013 Sep; 28(10):1360-9. PubMed ID: 23801590
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anatomical and functional correlates of persistent pain in Parkinson's disease.
    Polli A; Weis L; Biundo R; Thacker M; Turolla A; Koutsikos K; Chaudhuri KR; Antonini A
    Mov Disord; 2016 Dec; 31(12):1854-1864. PubMed ID: 27704616
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cortical thickness and gyrification index measuring cognition in Parkinson's disease.
    Chaudhary S; Kumaran SS; Goyal V; Kaloiya GS; Kalaivani M; Jagannathan NR; Sagar R; Mehta N; Srivastava AK
    Int J Neurosci; 2021 Oct; 131(10):984-993. PubMed ID: 32423354
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aberrant cerebral network topology and mild cognitive impairment in early Parkinson's disease.
    Pereira JB; Aarsland D; Ginestet CE; Lebedev AV; Wahlund LO; Simmons A; Volpe G; Westman E
    Hum Brain Mapp; 2015 Aug; 36(8):2980-95. PubMed ID: 25950288
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cortical thinning associated with mild cognitive impairment in Parkinson's disease.
    Segura B; Baggio HC; Marti MJ; Valldeoriola F; Compta Y; Garcia-Diaz AI; Vendrell P; Bargallo N; Tolosa E; Junque C
    Mov Disord; 2014 Oct; 29(12):1495-503. PubMed ID: 25100674
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Grey matter atrophy in cognitively impaired Parkinson's disease.
    Melzer TR; Watts R; MacAskill MR; Pitcher TL; Livingston L; Keenan RJ; Dalrymple-Alford JC; Anderson TJ
    J Neurol Neurosurg Psychiatry; 2012 Feb; 83(2):188-94. PubMed ID: 21890574
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Freezing of gait is associated with cortical thinning in mesial frontal cortex.
    Vastik M; Hok P; Valosek J; Hlustik P; Mensikova K; Kanovsky P
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2017 Dec; 161(4):389-396. PubMed ID: 28928491
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tremor severity in Parkinson's disease and cortical changes of areas controlling movement sequencing: A preliminary study.
    Benito-León J; Serrano JI; Louis ED; Holobar A; Romero JP; Povalej-Bržan P; Bermejo-Pareja F; Del Castillo MD; Posada IJ; Rocon E
    J Neurosci Res; 2018 Aug; 96(8):1341-1352. PubMed ID: 29660812
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Correlation of dopaminergic terminal dysfunction and microstructural abnormalities of the basal ganglia and the olfactory tract in Parkinson's disease.
    Scherfler C; Esterhammer R; Nocker M; Mahlknecht P; Stockner H; Warwitz B; Spielberger S; Pinter B; Donnemiller E; Decristoforo C; Virgolini I; Schocke M; Poewe W; Seppi K
    Brain; 2013 Oct; 136(Pt 10):3028-37. PubMed ID: 24014521
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.